Retrospective Epidemiology Study Of ALK Rearrangement In Non-Small Cell Lung Cancer Patients In The Middle East & North Africa
Condition(s):Non-small Cell Lung CancerLast Updated:July 19, 2019Completed
Hide Studies Not Open or Pending
Condition(s):Non-small Cell Lung CancerLast Updated:July 19, 2019Completed
Condition(s):Non-small Cell Lung Cancer Harboring ROS1 RearrangementLast Updated:January 11, 2019Unknown status
Condition(s):ROS1 Rearrangement Non-small Cell Lung Cancer; ALK Rearrangement Non-small Cell Lung CancerLast Updated:September 24, 2021Unknown status
Condition(s):Healthy VolunteersLast Updated:October 19, 2021Completed
Condition(s):Advanced Cholangiocarcinoma; FGFR2 Gene RearrangementsLast Updated:January 9, 2024Active, not recruiting
Condition(s):MPN (Myeloproliferative Neoplasms)Last Updated:December 6, 2023Active, not recruiting
Condition(s):Lung NeoplasmsLast Updated:December 8, 2020Completed
Condition(s):DLBCL; Untreated; MYC Gene RearrangementLast Updated:June 16, 2020Recruiting
Condition(s):Advanced Cholangiocarcinoma; FGFR2 Fusions; Gene RearrangementLast Updated:March 8, 2024Recruiting
Condition(s):Intrahepatic Cholangiocarcinoma; FGFR2 Gene Mutation; FGFR2 Gene Rearrangement; FGFR2 Gene TranslocationLast Updated:August 28, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.